Phase II trial of concurrent sunitinib and image-guided radiotherapy for oligometastases.

Phase II trial of concurrent sunitinib and image-guided radiotherapy for oligometastases.

Preclinical data suggest that sunitinib enhances the efficacy of radiotherapy. We tested the combination of sunitinib and hypofractionated image-guided radiotherapy (IGRT) in a cohort of patients with historically incurable distant metastases.Twenty five patients with oligometastases, defined as 1-5...

Full description

Bibliographic Details
Main Authors: Charles C L Tong, Eric C Ko, Max W Sung, Jamie A Cesaretti, Richard G Stock, Stuart H Packer, Kevin Forsythe, Eric M Genden, Myron Schwartz, K H Vincent Lau, Matthew Galsky, Junko Ozao-Choy, Shu-Hsia Chen, Johnny Kao
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3384658?pdf=render

Internet

http://europepmc.org/articles/PMC3384658?pdf=render

Similar Items